Citation Impact
Citing Papers
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
The Treatment of Chronic Viral Hepatitis
1997
Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy
1996
Extrahepatic Manifestations of Hepatitis C Infection
2003
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection
1997
Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: A long‐term followup study
2006
Syphilis
2016 Standout
Polyarteritis Nodosa and Extrahepatic Manifestations of HBV Infection: The Case Against Autoimmune Intervention in Pathogenesis
2001
Liver fibrosis
2005 Standout
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Hepatitis C Virus Infection
2001 Standout
Small-Vessel Vasculitis
1997 Standout
Interferon-? may exacerbate cryoglobulinemia-related ischemic manifestations: An adverse effect potentially related to its anti-angiogenic activity
1999
Association Of Hepatitis C Virus Infection With False-Positive Tests For Syphilis
1994
RENAL DISEASE ASSOCIATED WITH HEPATITIS C INFECTION AFTER KIDNEY AND LIVER TRANSPLANTATION1
2000
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency
2003
Multicenter Study on Hepatitis C Virus–Related Cryoglobulinemic Glomerulonephritis
2007
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Cryoglobulinemia Related to Hepatitis C Virus Infection
2007
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Course and outcome of hepatitis C
2002
Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia
1997
The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection
2001
Evidence‐based treatment of systemic vasculitis
2000
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Extrahepatic manifestations of HCV infection: facts and controversies
1999
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Hepatitis C virus–induced cryoglobulinemia
2009
Acute Renal Failure
1996 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Treatment of hepatitis C-virus-related glomerulonephritis
2006
Neurological manifestations of chronic hepatitis C
1999
Predictors of proteinuria and renal failure among women with HIV infection
2002
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
The Clinical Picture of Acute and Chronic Hepatitis C
1998
The Antiphospholipid Syndrome
2002 Standout
A comprehensive study of the association between hepatitis C virus and glomerulopathy
2002
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage
1994
Treatment of the childhood haemolytic uraemic syndrome with plasma
1988
Natural history of HCV infection
2000
Detection of Occult Low–Grade B–Cell Non–Hodgkin's Lymphoma in Patients With Chronic Hepatitis C Infection and Mixed Cryoglobulinemia
1999
Cryoglobulinemic glomerulonephritis: A membranoproliferative glomerulonephritis induced by hepatitis C virus
1995
Hepatitis C and renal disease: an update
2003
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Pathogenesis and treatment of renal failure in multiple myeloma
2008
Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process
2000
Hepatitis C virus infection and non‐hodgkin lymphoma: Results of the NCI‐seer multi‐center case‐control study
2004
Hepatitis C Virus Entry
2007 StandoutNobel
PEGylated interferon alfa‐2b and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis
2005
Interferon-α in combination with ribavirin as initial treatment for hepatitis C virus–associated cryoglobulinemic membranoproliferative glomerulonephritis
2001
Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial
1988
Clonal B‐cell expansions in peripheral blood of HCV‐infected patients
1995
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
The pathophysiology and management of thrombotic thrombocytopenic purpura
1996
Recurrent miscarriage
2006 Standout
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Treatment of HCV in Patients with Renal Failure
2007
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Hepatitis C: Natural History of a Unique Infection
1995
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Plasma Infusion as Treatment for 33 Children With Haemolytic Uraemic Syndrome: A Good Therapy ?
1993
MIXED CRYOGLOBULINEMIA SECONDARY TO HEPATITIS C VIRUS INFECTION
1996
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes
1999
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Mutations in Immunodominant T Cell Epitopes Derived from the Nonstructural 3 Protein of Hepatitis C Virus Have the Potential for Generating Escape Variants That May Have Important Consequences for T Cell Recognition
1999
Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome
1984
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy.
1998
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis
1998
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage Lunel F, Mussel L, Cacoub P, Frangeul, Cresta P, Perrin M, Grippon P, Hoang C, Piette JC, Huraux JH, Opolon P. Gastroenterology 1994;106:1291?1300
1995
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection
2002
Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
2005
1 Arachidonate Metabolism in Blood Cells and the Vessel Wall
1986
Hepatitis C Virus (HCV) and Lymphomagenesis
2003
Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2
2000
Course and outcome of hepatitis C
2002
Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia
2000
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Somatic Hypermutation, Clonal Diversity, and Preferential Expression of the VH 51p1/VL kv325 Immunoglobulin Gene Combination in Hepatitis C Virus–Associated Immunocytomas
1998
Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
2000
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
1982
Response to interferon α treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus
1999
The Hypercoagulable States
1985
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.
1993
Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
1982
Coronary Plaque Disruption
1995 Standout
Somatic Hypermutation, Clonal Diversity, and Preferential Expression of the VH 51p1/VL kv325 Immunoglobulin Gene Combination in Hepatitis C Virus–Associated Immunocytomas
1998
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Efficacy and safety of rituximab in type II mixed cryoglobulinemia
2003
Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen
1985
The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection
2001
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Multiple Myeloma
2011 Standout
Serum levels of free fatty acids in the first trimester of pregnancy: Effect of acetylsalicylic acid
1982
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders
1996
Monoclonal Proteins and Renal Disease
1994
Efficacy of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions
1984
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of Rocco Misiani being referenced
Haemolytic uraemic syndrome: therapeutic effect of plasma infusion.
1982
Plasmatic regulation of vascular prostacyclin in pregnancy.
1981
Hepatitis C virus–related cryoglobulinemic glomerulonephritis: Long-term remission after antiviral therapy
2003
Hepatitis C Virus Infection in Patients with Essential Mixed Cryoglobulinemia
1992
Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-&agr; and ribavirin
1999
Interferon Alfa-2a Therapy in Cryoglobulinemia Associated with Hepatitis C Virus
1994
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia
1980
Management of Myeloma Kidney: An Anti-Light-Chain Approach
1987
Prostacyclin and Thrombotic Microangiopathy
1980
Treatment of the hemolytic uremic syndrome with plasma.
1979
Familial deficiency of a plasma factor stimulating vascular prostacyclin activity
1979
GB Virus C Infection in Patients with Type II Mixed Cryoglobulinemia
1997